Edgewise Therapeutics
EWTX
46 hedge funds and large institutions have $1.03B invested in Edgewise Therapeutics in 2021 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 8 closing their positions.
188% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 8
50% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 6
48% more funds holding
Funds holding: 31 → 46 (+15)
1.18% more ownership
Funds ownership: 96.03% → 97.21% (+1.2%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
30% less capital invested
Capital invested by funds: $1.48B → $1.03B (-$449M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$24.2M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$21.9M |
| 3 |
BlackRock
New York
|
+$14M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.7M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$6.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$17.1M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$9.75M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$9.61M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$4.03M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$3.25M |
EWTX Hedge Fund Activity: Q2 2021 in Review
46 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Edgewise Therapeutics (EWTX) for Q2 2021, worth a combined $1.03B — down 30% from $1.48B a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new EWTX positions and 8 closed out — a net gain of 15 holders — while 9 added to existing stakes and 6 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $24.2M. The largest seller was Viking Global Investors, cutting an estimated $17.1M.
- 46 institutional investors held Edgewise Therapeutics (EWTX) as of Q2 2021, up from 31 in Q1 2021.
- Funds reported $1.03B of Edgewise Therapeutics stock for Q2 2021, down 30% quarter-over-quarter.
- 23 funds opened new Edgewise Therapeutics positions in Q2 2021 and 8 closed out, a net change of +15 holders.
- The largest Edgewise Therapeutics buyer in Q2 2021 was Fidelity Investments, an estimated $24.2M added.
- The largest Edgewise Therapeutics seller in Q2 2021 was Viking Global Investors, an estimated $17.1M sold.
Based on aggregated 13F filings for Q2 2021.